SIRT3 and pulmonary arterial hypertension: The implications of these findings are that in the context of PAH, treatments or interventions targeting SIRT3 and mitochondrial function in skeletal muscles could lead to improvements in functional status, as indicated by increased 6MWD, potentially enhancing the quality of life for the patient.